Symbol: TMO Sector: Healthcare Industry: Medical Diagnostics & Research
Update: 2019-06-10 21:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2019-03-31 |
6,125,000,000 |
6,125,000,000 |
3,293,000,000 |
2,832,000,000 |
1,901,000,000 |
931,000,000 |
815,000,000 |
9,939,000,000 |
55,596,000,000 |
27,903,000,000 |
- |
1,128,000,000 |
1,336,000,000 |
1,106,000,000 |
18,148,000,000 |
-957,000,000 |
649,000,000 |
248,000,000 |
Update: 2019-06-10 21:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2018-12-31 |
6,507,000,000 |
6,507,000,000 |
3,583,000,000 |
2,924,000,000 |
1,761,000,000 |
1,163,000,000 |
898,000,000 |
10,625,000,000 |
56,232,000,000 |
28,646,000,000 |
27,586,000,000 |
2,117,000,000 |
1,271,000,000 |
2,103,000,000 |
18,990,000,000 |
1,067,000,000 |
1,801,000,000 |
251,000,000 |
2018-09-30 |
5,920,000,000 |
5,920,000,000 |
3,305,000,000 |
2,615,000,000 |
1,730,000,000 |
885,000,000 |
709,000,000 |
9,566,000,000 |
55,078,000,000 |
28,188,000,000 |
26,890,000,000 |
1,111,000,000 |
1,014,000,000 |
1,098,000,000 |
18,774,000,000 |
176,000,000 |
1,220,000,000 |
240,000,000 |
2018-06-30 |
6,078,000,000 |
6,078,000,000 |
3,340,000,000 |
2,738,000,000 |
1,784,000,000 |
954,000,000 |
752,000,000 |
9,474,000,000 |
55,403,000,000 |
28,958,000,000 |
26,445,000,000 |
956,000,000 |
1,711,000,000 |
937,000,000 |
19,420,000,000 |
253,000,000 |
1,444,000,000 |
242,000,000 |
2018-03-31 |
5,853,000,000 |
5,853,000,000 |
3,273,000,000 |
2,580,000,000 |
1,749,000,000 |
831,000,000 |
579,000,000 |
9,588,000,000 |
56,580,000,000 |
30,457,000,000 |
26,123,000,000 |
975,000,000 |
2,814,000,000 |
950,000,000 |
20,936,000,000 |
-443,000,000 |
78,000,000 |
234,000,000 |
Update: 2019-06-10 21:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2017-12-31 |
6,047,000,000 |
6,047,000,000 |
3,379,000,000 |
2,668,000,000 |
1,701,000,000 |
967,000,000 |
528,000,000 |
9,421,000,000 |
56,669,000,000 |
31,256,000,000 |
25,413,000,000 |
1,361,000,000 |
2,135,000,000 |
1,335,000,000 |
21,008,000,000 |
439,000,000 |
1,866,000,000 |
234,000,000 |